Perlmutter Cancer Center earned Comprehensive status from the National Cancer Institute
On Feb. 6, 2019, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health was designated a Comprehensive…
On Feb. 6, 2019, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health was designated a Comprehensive…
On Jan. 30, 2019, the Government of Canada announced an investment of $18 million over five years in…
On Jan. 29, 2019, Ontario Institute for Cancer Research’s (OICR) Drug Discovery Program’s first-of-its-kind leukemia therapy discovery received…
On Jan. 24, 2019, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published the first genetic…
On Jan. 24, 2019, the Barbara Ann Karmanos Institute received the President’s Trophy from McLaren Health Care system,…
On Jan. 24, 2019, Pascal Biosciences announced the testing of cannabinoids in human subjects for its immune stimulatory…
On Jan. 23, 2019, U.S. Food and Drug Administration (FDA) announced it had approved approved the use of…
On Jan. 22, 2019, GlaxoSmithKline acquired TESARO based in Waltham, Massachusetts, for an aggregate cash consideration of approximately…
On Jan. 21, 2019, researchers at Fred Hutchinson Cancer Research Center announced finding a way to essentially smother…
On Jan. 18, 2019 Masonic Cancer Center researchers received $1.4 million in grants for ovarian cancer research from…
On Jan. 18, 2019, Masonic Cancer Center researcher Branden Moriarity, PhD, received a U24 Grant with Recombinetics. The…
On Jan. 14, 2019, Sanofi announced the FDA had approved the expanded use of Adacelᆴ (Tetanus Toxoid, Reduced…
On Jan. 9, 2019, AstraZeneca announced it had closed plants in Colorado and layed off 210 workers. AstraZeneca…
On Jan. 8, 2019, Takeda Pharmaceutical announced the completion of its acquisition of Lexington, Massachusetts-based Shire for a…
On Jan. 7, 2019, the Emory University School of Medicine received a $500,000 grant from the Centers for…
In 1939, Martin Health was founded in 1939 with an original hospital that had 23 beds, three physicians,…
In 2019, Calibr began using robotics as an emerging drug discovery model to accelerate new medicines and fund…
In 2019, the Quebec Scientific Entrepreneurship Program (QcSE) launched as an online program for scientists and STEM researchers…